Replay
Replay is a biotechnology company focused on developing high-capacity HSV vectors for gene therapy applications. The company utilizes a genome writing platform to reprogram biology by writing and delivering large-scale DNA sequences. Their work targets the development of advanced genomic medicines for various therapeutic areas.
Visit websiteSan Diego, USA
Biotechnology
Gene Therapy
Healthtech
Funding summary
- Total raised
- €54.3M
- Funding rounds
- 1
Investors in Replay
Investors on record for Replay. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Replay?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors